Skip to main content
COLL logo

COLL

Collegium Pharmaceutical, Inc.

$36.72

4.85%

Trade Ideas Performance

Latest Closed Trade Idea

$36.72

4.85%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

9

Social

16

About

Events of Collegium Pharmaceutical, Inc. (COLL)

In the past six months, Collegium Pharmaceutical reported strong first-quarter 2026 results, exceeding market revenue expectations, which led to the stock soaring. Collegium announced plans to acquire the ADHD medicine AZSTARYS, which is expected to be immediately accretive to adjusted EBITDA. The company reported its fourth quarter and full-year 2025 financial results and raised its full-year 2025 net product revenue guidance earlier. Collegium Pharmaceutical insiders have sold more of their company's stock than they have bought, with sales totaling $2,507,572.00.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Collegium Pharmaceutical, Inc. (COLL) Live Stock Price, Chart & Financial News | Edge Hound